CD274 and small cell lung carcinoma: For extensive-stage small cell lung cancer (SCLC), the first-line treatment usually consists of chemotherapy combined with immunotherapy, such as PD-L1 inhibitors (Atezolizumab), while second-line treatment relies more on single-agent chemotherapy or single-agent immunotherapy.